Latest Breaking News On - Prnewswire eccogene - Page 1 : comparemela.com

Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases

Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPrnewswire eccogeneSharon barrJingye zhouEccogene incChief executive officerExecutive vice president

Eccogene Announces US IND Approval for THRβ agonist ECC4703

/PRNewswire/ Eccogene announced that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application to commence.

Prnewswire eccogeneJingye zhouDrug administration

Latest Breaking News On - Prnewswire eccogene - Page 1 : comparemela.com

Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases

Eccogene Announces US IND Approval for THRβ agonist ECC4703

/PRNewswire/ Eccogene announced that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application to commence.Prnewswire eccogeneJingye zhouDrug administration

/PRNewswire/ Eccogene announced that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application to commence.

Prnewswire eccogeneJingye zhouDrug administration